Unity Biotechnology's corporate restructuring is a cash-saving move that allows the company to focus resources on its lead program, a drug in Phase 2 testing for diabetic macular edema and wet age-related macular degeneration. Unity previously restructured in 2020 following the Phase 2 failure of its osteoarthritis drug.
At a time when a large portion of healthcare practitioner interactions have switched to digital, it's clear that life science companies need to transform their approach to be much more collaborative in the way they work with healthcare professionals.
A new survey from Reuters Events in collaboration with Microsoft and Exeevo, Medical-commercial collaborating to win in the digital era, offers an inside look at the trends and challenges with which life science professionals have to contend, and how they are responding and explores new strategies and tactics for how these companies are working with healthcare providers and adapting themselves to improve the patient experience in healthcare.
We are extending our INVEST 2022 Pitch Perfect deadline to Feb 11, 11:59 p.m. ET to allow interested startups to apply to the 4 tracks - PharmaTech, Diagnostics 2.0, Care Coordination and Value-Based Care, and Remote Patient Monitoring and Smart Devices. Slots are going fast so we encourage all startups - particularly those interested to apply in the PharmaTech and Diagnostics tracks to apply immediately. Selected startups will get to pitch LIVE on stage in front of VC judges. Here's the agenda for the INVEST conference.
By Bernard J. Wolfson and Angela Hart and Samantha Young, Kaiser Health News Friday, February 4, 2022 7:01 PM
Dr. Bechara Choucair, Kaiser Permanente's chief health officer, argued in a prepared written response on behalf of KP that because it operates both as a health insurer and a healthcare provider, KP should be treated differently than other commercial health plans that participate in Medi-Cal.
Komodo Health partnered with non-profit Chan Zuckerberg Initiative's Rare as One Network to offer their Healthcare Map technology for identifying patient populations and studying rare disease trends.
A CMS rule, which went into effect December 31, requires that providers publish up-to-date digital contact information regarding their compliance, using approved methods. Noncompliant hospitals will be publicly listed, akin to the Office of Civil Rights' breach notification portal, the so-called "Wall of Shame."
By Frank Vinluan Friday, February 4, 2022 12:17 PM
Unity Biotechnology's corporate restructuring is a cash-saving move that allows the company to focus resources on its lead program, a drug in Phase 2 testing for diabetic macular edema and wet age-related macular degeneration. Unity previously restructured in 2020 following the Phase 2 failure of its osteoarthritis drug.
No comments